TheraRadar
Data updated: May 26, 2026

E-Z-DISK (barium sulfate)

X-Ray Contrast Activity
Other Approved 2025-08-01

E-Z-DISK is a radiographic contrast agent used to check the openness of the esophagus in adults and children 12 years and older. It helps healthcare providers evaluate esophageal patency by determining if the disk can successfully pass through the esophageal tube into the stomach. This diagnostic tool is used during imaging procedures to identify potential narrowing or obstructions in the esophagus.

Source: FDA Label • BRACCO • Radiographic Contrast Agent

How E-Z-DISK Works

Because barium has a high atomic number, it is opaque to X-rays and acts as a positive contrast agent during radiographic studies. The disk is specifically sized to pass into the stomach only when the esophageal opening is wider than 11.5 mm to 13.5 mm, allowing clinicians to visualize the physical dimensions of the passage.

1
Indication
--
Phase 3 Trials
0
Years on Market

Details

Status
Prescription
First Approved
2025-08-01
Routes
ORAL
Dosage Forms
TABLET

Companies

Active Ingredient: BARIUM SULFATE

E-Z-DISK Approval History

2026
Original
New Indication
New Form
Label Update
1 FDA actions from 2025 to 2025
Aug 2025 ORIGINAL
Update · Type 7 - Drug Already Marketed without Approved NDA

What E-Z-DISK Treats

1 indications

E-Z-DISK is approved for 1 conditions since its original approval in 2025. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Esophageal Patency
Source: FDA Label
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

E-Z-DISK FDA Label Details

Indications & Usage

FDA Label (PDF)

E-Z-DISK is indicated for the treatment of Esophageal Patency.

Track E-Z-DISK with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.